These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 4573494)

  • 1. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 2. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluspirilene, a long-acting injectable neuroleptic.
    Ciccarelli G; Nosé F; Zuanazzi GF
    Acta Psychiatr Belg; 1972 Nov; 72(6):736-47. PubMed ID: 4679675
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
    Bruck J; Guss H
    Int Pharmacopsychiatry; 1974; 9(3):152-65. PubMed ID: 4154320
    [No Abstract]   [Full Text] [Related]  

  • 5. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.
    Ota KY; Kurland AA; Slotnick VB
    J Clin Pharmacol; 1974 Apr; 14(4):202-9. PubMed ID: 4595986
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia.
    White AC; Sims AC
    Curr Med Res Opin; 1974; 2(1):23-6. PubMed ID: 4841811
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
    Vandecasteele AJ; Vereecken JL
    Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data].
    Mormont C
    Acta Psychiatr Belg; 1972 Sep; 72(5):595-601. PubMed ID: 4669431
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with an oral, long-term neuroleptic agent: penfluridol].
    Floru L; Zurborn R
    Med Welt; 1973 Apr; 24(15):600-3. PubMed ID: 4744987
    [No Abstract]   [Full Text] [Related]  

  • 12. [Report on the clinical test of the long-term neuroleptic agent penfluridol].
    Glatzel J
    Med Welt; 1973 Dec; 24(51):2044-6. PubMed ID: 4204355
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of haloperidol and penfluridol on the learning capacity of the schizophrenic.
    Van Lommel R; Baro F; Dom R
    Arzneimittelforschung; 1974 Jul; 24(7):1072-4. PubMed ID: 4605278
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long term neuroleptic therapy using fluspirilene and penfluridol].
    Haase HJ; Fischer D; Floru L; Frank T; Joseph K; Knaack M; Mohr W; Richter-Peill H; Steuer A; Wahl G; Walterbusch G; Zurborn R
    Nervenarzt; 1971 Dec; 42(12):632-7. PubMed ID: 5134761
    [No Abstract]   [Full Text] [Related]  

  • 15. [Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene].
    Ciccarelli G; Nosè F
    Minerva Med; 1971 Dec; 62(98):4922-7. PubMed ID: 5141918
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of clinical efficacy of pimozide as maintenance therapy in chronic schizophrenic patients.
    Singh AN
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):695-705. PubMed ID: 5000717
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia.
    Tanghe A; Vereecken JL
    Acta Psychiatr Scand; 1972; 48(4):315-31. PubMed ID: 4566564
    [No Abstract]   [Full Text] [Related]  

  • 18. Penfluridol: an efficacious long-acting oral antipsychotic compound.
    Gallant DM; Mielke DH; Spirtes MA; Swanson WC; Bost R
    Am J Psychiatry; 1974 Jun; 131(6):699-702. PubMed ID: 4597305
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.
    Iqbal MJ; Young MA; Charles J; Elgart B; Von Greiff H; Simpson GM
    J Clin Psychiatry; 1978 Apr; 39(4):375-9. PubMed ID: 580285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.